Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in Bangladesh

International Journal of Diabetes in Developing Countries

Volumn 30, Issue 1, 2010, Pages 11-17

  Mørkrid, Kjersti ^a   Ali, Liaquat ^b   Hussain, Akhtar ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Bangladesh Institute of Research and Rehabilitation in Diabetes Endocrine and Metabolic Disorders   (Bangladesh)

Author keywords

Peripheral neuropathy; Risk factors; Type 2 diabetes

Indexed keywords

EID: 77949634175     PISSN: 09733930     EISSN: 19983832     Source Type: Journal    
DOI: 10.4103/0973-3930.60004     Document Type: Article

References (26)

1. Boulton AJ, Cavanagh PR, Rayman G. The foot in diabetes. 4th ed. John Wiley & Sons Ltd; 2006.
2. Report and recommendations of the San Antonio conference on diabetic neuropathy. Neurology 1988;38:1161-1165
3. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005;366:1719-1724
4. Boulton AJ. The diabetic foot: from art to science: The 18th Camillo Golgi lecture. Diabetologia 2004;47:1343-1353
5. Vinik AI, Mehrabyan A. Diabetic neuropathies. Med Clin North Am 2004;88:947-99, xi.
6. Abbott CA, Garrow AP, Carrington AL, Morris J, Van Ross ER, Boulton AJ, et al. Foot ulcer risk is lower in South-Asian and African-Caribbean compared with European diabetic patients in the UK: The North-West diabetes foot care study. Diabetes Care 2005;28:1869-1875
7. Chaturvedi N, Abbott CA, Whalley A, Widdows P, Leggetter SY, Boulton AJ. Risk of diabetes-related amputation in South Asians vs Europeans in the UK. Diabet Med 2002;19:99-104.
8. Chaturvedi N, Stevens LK, Fuller JH, Lee ET, Lu M. Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes: The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001;44:S65-71.
9. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053
10. Hussain A, Rahim MA, Azad Khan AK, Ali SM, Vaaler S. Type 2 diabetes in rural and urban population: Diverse prevalence and associated risk factors in Bangladesh. Diabet Med 2005;22:931-936
11. Wahid S. BIRDEM: A WHO Collaborating Centre in Bangladesh. Vol.4, WHO: Window on SEAR; 2004. p. 10-11
12. Börü UT, Alp R, Sargin H, Koçer A, Sargin M, Lüleci A, et al. Prevalence of peripheral neuropathy in type 2 diabetic patients attending a diabetes center in Turkey. Endocr J 2004;51:563-567
13. Ahn CW, Song YD, Kim JH, Lim SK, Choi KH, Kim KR, et al. The validity of random urine specimen albumin measurement as a screening test for diabetic nephropathy. Yonsei Med J 1999;40:40-45
14. Incerti J, Zelmanovitz T, Camargo JL, Gross JL, de Azevedo MJ. Evaluation of tests for microalbuminuria screening in patients with diabetes. Nephrol Dial Transplant 2005;20:2402-2407
15. Vaage JT. Laboratoriehåndbok for Avdeling for medisinsk biokjemi: Gaustad; 2007.
16. Barbosa AP, Medina JL, Ramos EP, Barros HP. Prevalence and risk factors of clinical diabetic polyneuropathy in a Portuguese primary health care population. Diabetes Metab 2001;27:496-502.
17. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-154
18. Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: A study in primary care and hospital clinic groups: Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia 1998;41:1263-1269
19. Ashok S, Ramu M, Deepa R, Mohan V. Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India. J Assoc Physicians India 2002;50:546-550
20. Ramachandran A. Specific problems of the diabetic foot in developing countries. Diabetes Metab Res Rev 2004;20:S19-22.
21. Janghorbani M, Rezvanian H, Kachooei A, Ghorbani A, Chitsaz A, Izadi F, et al. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: Prevalence and risk factors. Acta Neurol Scand 2006;114:384-391
22. Mimi O, Teng CL, Chia YC. The prevalence of diabetic peripheral neuropathy in an outpatient setting. Med J Malaysia 2003;58:533-538
23. Jarmuzewska EA, Ghidoni A, Mangoni AA. Hypertension and sensorimotor peripheral neuropathy in type 2 diabetes. Eur Neurol 2007;57:91-95
24. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:341-350
25. Savage S, Estacio RO, Jeffers B, Schrier RW. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: A population study. Proc Assoc Am Physicians 1997;109:181-189
26. Karim F, Tripura A, Gani MS, Chowdhury AM. Poverty status and health equity: Evidence from rural Bangladesh. Public Health 2006;120:193-205.